Medicine i_need_contribute
COVID-19 vaccine progress in Argentina
source：CGTN 2020-08-24 [Medicine]
Last week, Argentina and Mexico announced they will produce the coronavirus vaccine jointly developed by Oxford University and pharmaceutical company AstraZeneca.

And on Friday, Argentina announced it will run a phase 3 trial with one of the vaccines developed by China. 

Progress toward a licensed COVID-19 vaccine is some much needed positive news in Latin America—which now has the highest number of cases and deaths in the world.

previous：Federal Study of Covid Treatments Enters a New Phase next：Belgian students to self-collect saliva in large COVID-19 testing experiment
related_info